Yutian Zou Selected Research

Yutian Zou Research Topics

Disease

31	Neoplasms (Cancer) 04/2024 - 01/2019
16	Breast Neoplasms (Breast Cancer) 12/2023 - 01/2020
15	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2019
14	Triple Negative Breast Neoplasms 03/2024 - 01/2019
3	Carcinogenesis 01/2022 - 12/2019
2	Lymphatic Metastasis 01/2020 - 01/2020
1	Genomic Instability 12/2023
1	Communicable Diseases (Infectious Diseases) 12/2023
1	Vertigo (Positional Vertigo) 01/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2023
1	Dizziness (Lightheadedness) 01/2023
1	Dyslipidemias (Dyslipidemia) 01/2023
1	Stroke (Strokes) 01/2023
1	Disease Progression 01/2022
1	Microsatellite Instability 01/2021
1	Hypoxia (Hypoxemia) 11/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Glioma (Gliomas) 12/2019
1	Atherosclerosis 11/2019

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2019
8	Circular RNAIBA 06/2021 - 01/2019
7	Proteins (Proteins, Gene)FDA Link 12/2023 - 12/2019
7	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2019
3	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2020
2	LipidsIBA 01/2023 - 01/2022
2	BiglycanIBA 01/2023 - 01/2022
2	oxidized low density lipoproteinIBA 01/2023 - 11/2019
2	Phenobarbital (Luminal)FDA Link 11/2022 - 01/2020
2	Long Noncoding RNAIBA 03/2020 - 01/2020
2	Peptides (Polypeptides)IBA 01/2020 - 11/2019
2	snake venom protein C activatorIBA 01/2020 - 01/2019
1	Apolipoproteins E (ApoE)IBA 04/2024
1	Glycogen Synthase (Synthase I)IBA 03/2024
1	Piwi-Interacting RNAIBA 12/2023
1	Histone ChaperonesIBA 12/2023
1	Aurora Kinase AIBA 12/2023
1	VaccinesIBA 12/2023
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	Immune Checkpoint ProteinsIBA 01/2023
1	CateninsIBA 01/2023
1	CholesterolIBA 01/2023
1	Heterogeneous-Nuclear Ribonucleoprotein KIBA 01/2023
1	HDL CholesterolIBA 01/2023
1	LDL CholesterolIBA 01/2023
1	VLDL CholesterolIBA 01/2023
1	beta CateninIBA 12/2022
1	Transcription Factors (Transcription Factor)IBA 12/2022
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2022
1	Indicators and Reagents (Reagents)IBA 11/2022
1	palbociclibIBA 11/2022
1	Docetaxel (Taxotere)FDA Link 11/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2022
1	N-methyladenosineIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Potassium Channels (Potassium Channel)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021
1	human ERBB2 proteinIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 06/2020
1	Endoplasmic Reticulum Chaperone BiPIBA 06/2020
1	Therapeutic UsesIBA 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	Proteolysis Targeting ChimeraIBA 01/2020
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2019
1	Untranslated RNA (Noncoding RNA)IBA 12/2019
1	LuciferasesIBA 12/2019
1	humaninIBA 11/2019
1	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 11/2019
1	Competitive Endogenous RNAIBA 01/2019

Therapy/Procedure

14	Therapeutics 04/2024 - 01/2019
14	Immunotherapy 04/2024 - 01/2020
3	Mastectomy (Mammectomy) 01/2021 - 01/2020
1	Drug Therapy (Chemotherapy) 11/2022
1	Adjuvant Chemotherapy 11/2022
1	Segmental Mastectomy (Lumpectomy) 01/2021
1	Contraindications 01/2020